EMEA-002791-PIP01-20 - paediatric investigation plan
Chimeric fibril-reactive IgG1k monoclonal antibody 11-1F4
PIPHuman
Key facts
- Active Substance
- Chimeric fibril-reactive IgG1k monoclonal antibody 11-1F4
- Therapeutic area
- Endocrinology-Gynaecology-Fertility-Metabolism
- Decision number
- P/0449/2020
- PIP number
- EMEA-002791-PIP01-20
- Pharmaceutical form(s)
- Solution for infusion
- Condition(s) / indication(s)
- Treatment of systemic light chain amyloidosis
- Route(s) of administration
- Intravenous use
- Contact for public enquiries
Real Regulatory Limited
Email: info@realregulatory.com
Tel. +353 18851710
- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date